← Back to Search

gamma-linolenic acid for Weight Gain/Loss Trajectory (GLASS Trial)

N/A
Waitlist Available
Led By Shaminie Athinarayanan, PhD
Research Sponsored by Virta Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 6, 12, 18, and 24 months
Awards & highlights

GLASS Trial Summary

This trial will show whether increasing GLA content will help people keep the weight off.

Eligible Conditions
  • Weight Gain/Loss Trajectory

GLASS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 6, 12, 18, and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 6, 12, 18, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in change in body weight between groups over time
Secondary outcome measures
Difference in blood glucose between groups over time
Whole Body Imaging
Difference in health-related quality of life between groups over time
+5 more

GLASS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: gamma-linolenic acid (GLA) supplementationExperimental Treatment1 Intervention
Sonova GLA safflower oil (840 mg GLA per day)
Group II: placebo controlPlacebo Group1 Intervention
1500 mg 'light' olive oil per day

Find a Location

Who is running the clinical trial?

Virta HealthLead Sponsor
4 Previous Clinical Trials
50,703 Total Patients Enrolled
Shaminie Athinarayanan, PhDPrincipal InvestigatorVirta Health
Rebecca Adams, PhDStudy DirectorVirta Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for those wishing to participate in this experimentation?

"Clinicaltrials.gov data suggests that the recruitment window for this particular trial has closed, with its first post dating back to July 22nd 2020 and last update occurring on October 11th 2022. Nevertheless, there are still 3 other medical studies in need of participants at present."

Answered by AI
~64 spots leftby Apr 2025